aTyr Pharma, Inc. – NASDAQ:ATYR
aTyr Pharma stock price today
aTyr Pharma stock price monthly change
aTyr Pharma stock price quarterly change
aTyr Pharma key metrics
Market Cap | 282.88M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeaTyr Pharma stock price history
aTyr Pharma stock forecast
aTyr Pharma financial statements
| 2015 | 0 | -47.97M | |
|---|---|---|---|
| 2017 | 0 | -48.20M | |
| 2020 | 10.45M | -16.22M | -155.18% |
| 2023 | 353K | -50.38M | -14274.5% |
| 2014 | 20644000 | 111.65M | 540.85% |
|---|---|---|---|
| 2015 | 129675000 | 14.62M | 11.28% |
| 2017 | 89355000 | 25.11M | 28.1% |
| 2023 | 120653000 | 30.18M | 25.02% |
| 2017 | -42.36M | -27.63M | 52.70M |
|---|---|---|---|
| 2019 | -20.01M | 4.92M | 1.33M |
| 2022 | -41.88M | 47.24M | 5.45M |
| 2023 | -33.22M | -20.12M | 66.23M |
aTyr Pharma alternative data
| Jul 2024 | 56 |
|---|---|
| Dec 2024 | 56 |
aTyr Pharma other data
| Period | Buy | Sel |
|---|---|---|
| Jun 2024 | 5000 | 0 |
| Jul 2024 | 100000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | SCHIMMEL PAUL director | Common Stock | 52,300 | $1.93 | $101,044 | ||
Purchase | SCHIMMEL PAUL director | Common Stock | 6,648 | $1.82 | $12,073 | ||
Purchase | SCHIMMEL PAUL director | Common Stock | 41,052 | $1.74 | $71,513 | ||
Purchase | DENYES NANCY officer: General .. | Common Stock | 5,000 | $1.86 | $9,275 | ||
Sale | ECOR1 CAPITAL FUND QUALIFIED, L.P. 10 percent owner | Common Stock | 1,083 | $3.95 | $4,278 | ||
Sale | ECOR1 CAPITAL FUND QUALIFIED, L.P. 10 percent owner | Common Stock | 5,860 | $4 | $23,446 | ||
Sale | ECOR1 CAPITAL FUND QUALIFIED, L.P. 10 percent owner | Common Stock | 5,819 | $4.15 | $24,149 | ||
Sale | ECOR1 CAPITAL FUND QUALIFIED, L.P. 10 percent owner | Common Stock | 1,070 | $4.3 | $4,601 | ||
Purchase | ECOR1 CAPITAL FUND QUALIFIED, L.P. 10 percent owner | Common Stock | 24,728 | $4.8 | $118,694 | ||
Purchase | ECOR1 CAPITAL FUND QUALIFIED, L.P. 10 percent owner | Common Stock | 4,879 | $5.05 | $24,639 |
Thursday, 12 December 2024 | ||
| aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors | globenewswire.com | |
Monday, 9 December 2024 | ||
| aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis | globenewswire.com |
-
What's the price of aTyr Pharma stock today?
One share of aTyr Pharma stock can currently be purchased for approximately $4.7.
-
When is aTyr Pharma's next earnings date?
Unfortunately, aTyr Pharma's (ATYR) next earnings date is currently unknown.
-
Does aTyr Pharma pay dividends?
No, aTyr Pharma does not pay dividends.
-
How much money does aTyr Pharma make?
aTyr Pharma has a market capitalization of 282.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 96.62% to 353K US dollars.
-
What is aTyr Pharma's stock symbol?
aTyr Pharma, Inc. is traded on the NASDAQ under the ticker symbol "ATYR".
-
What is aTyr Pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of aTyr Pharma?
Shares of aTyr Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does aTyr Pharma have?
As Dec 2024, aTyr Pharma employs 56 workers.
